HonCode

Go Back   HER2 Support Group Forums > Clinical Trials
Register Gallery FAQ Members List Calendar Search Today's Posts Mark Forums Read

Reply
 
Thread Tools Display Modes
Old 10-14-2009, 09:48 PM   #1
Rich66
Senior Member
 
Rich66's Avatar
 
Join Date: Feb 2008
Location: South East Wisconsin
Posts: 3,431
MediGene completes patient recruitment into EndoTAGTM-1 phase II breast cancer trial

MediGene completes patient recruitment into EndoTAGTM-1 phase II breast cancer trial


Wednesday, October 14, 2009 14:00 IST
Martinsried, Munich

MediGene AG has successfully completed patient recruitment into its randomized phase-II trial of EndoTAG-1 for the treatment of triple receptor-negative breast cancer. Results will be available as scheduled in the first six months of 2010. This multinational clinical trial is being conducted across more than 20 centres in Europe and India.

The trial was designed to enrol patients suffering from hormone receptor and HER-2-receptor negative breast cancer who have metastatic disease. The trial recruited 135 patients divided into three groups: EndoTAG-1 alone, EndoTAG-1 in combination with a cytotoxic drug or the cytotoxic drug alone. The study will assess safety, tolerability and efficacy. The primary endpoint of the trial is progression-free survival after 16 weeks.

Dr Axel Mescheder, CSO & CDO of MediGene AG, commented, "The completion of patient recruitment in this important trial is another key milestone for MediGene which also shows the high degree of acceptance of this treatment among physicians and patients. It also ensures that we will be able to conclude the trial within the projected time frame. This controlled trial has been powered to allow the assessment of both the efficacy and the safety of EndoTAG-1 in this very difficult to treat cancer population."

The drug candidate EndoTAG-1 selectively attacks blood vessels needed for the growth of tumours.

MediGene AG is a publicly listed biotechnology company located in Martinsried/Munich, Germany, with subsidiaries in Oxford, UK and San Diego, USA.
Rich66 is offline   Reply With Quote
Reply

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


All times are GMT -7. The time now is 10:56 AM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2018, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007
free webpage hit counter